rs201061729
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_032289.4(PSD2):c.689G>A(p.Arg230His) variant causes a missense change. The variant allele was found at a frequency of 0.0000663 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032289.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSD2 | NM_032289.4 | c.689G>A | p.Arg230His | missense_variant | Exon 3 of 15 | ENST00000274710.4 | NP_115665.1 | |
PSD2 | XM_017009976.2 | c.689G>A | p.Arg230His | missense_variant | Exon 4 of 16 | XP_016865465.1 | ||
PSD2 | XM_017009977.2 | c.689G>A | p.Arg230His | missense_variant | Exon 4 of 16 | XP_016865466.1 | ||
PSD2 | XM_047417829.1 | c.689G>A | p.Arg230His | missense_variant | Exon 3 of 15 | XP_047273785.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000110 AC: 27AN: 244868 AF XY: 0.0000748 show subpopulations
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461546Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 49AN XY: 727088 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74354 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.689G>A (p.R230H) alteration is located in exon 3 (coding exon 2) of the PSD2 gene. This alteration results from a G to A substitution at nucleotide position 689, causing the arginine (R) at amino acid position 230 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at